Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly R Young

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Current Drug Targets. Infectious Disorders|May 29, 2003
Particle-based vaccines for HIV-1 infectionKelly R Young, Ted M Ross
AIDS Research and Human Retroviruses|January 28, 2006
Elicitation of immunity to HIV type 1 Gag is determined by Gag structureKelly R Young, Ted M Ross
Virology|September 8, 2004
Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particleKelly R Young, James M Smith, Ted M Ross
Virology|October 3, 2006
Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopesSean P McBurney, Kelly R Young, Ted M Ross
Methods (San Diego, Calif.)|September 26, 2006
Virus-like particles: designing an effective AIDS vaccineKelly R Young, Sean P McBurney, Lukena U Karkhanis, et al.
Journal of Virology|October 21, 2011
A novel self-replicating chimeric lentivirus-like particleChristy K Jurgens, Kelly R Young, Victoria J Madden, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodiesKelly R Young, Benjamin E Teal, Yvonne Brooks, et al.
Current HIV Research|November 1, 2006
Lentivirus-like particles without reverse transcriptase elicit efficient immune responsesSean P McBurney, Kelly R Young, Casmiar I Nwaigwe, et al.
Radiology|April 29, 2025
Improving Effectiveness of Liver US Shear-Wave Elastography Using a Quality Improvement FrameworkMasoud Baikpour, David Hunt, Jyoti Narayanswami, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Current Drug Targets. Infectious Disorders|May 29, 2003
Particle-based vaccines for HIV-1 infectionKelly R Young, Ted M Ross
AIDS Research and Human Retroviruses|January 28, 2006
Elicitation of immunity to HIV type 1 Gag is determined by Gag structureKelly R Young, Ted M Ross
Virology|September 8, 2004
Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particleKelly R Young, James M Smith, Ted M Ross
Virology|October 3, 2006
Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopesSean P McBurney, Kelly R Young, Ted M Ross
Methods (San Diego, Calif.)|September 26, 2006
Virus-like particles: designing an effective AIDS vaccineKelly R Young, Sean P McBurney, Lukena U Karkhanis, et al.
Journal of Virology|October 21, 2011
A novel self-replicating chimeric lentivirus-like particleChristy K Jurgens, Kelly R Young, Victoria J Madden, et al.
AIDS Research and Human Retroviruses|December 14, 2004
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodiesKelly R Young, Benjamin E Teal, Yvonne Brooks, et al.
Current HIV Research|November 1, 2006
Lentivirus-like particles without reverse transcriptase elicit efficient immune responsesSean P McBurney, Kelly R Young, Casmiar I Nwaigwe, et al.
Radiology|April 29, 2025
Improving Effectiveness of Liver US Shear-Wave Elastography Using a Quality Improvement FrameworkMasoud Baikpour, David Hunt, Jyoti Narayanswami, et al.
Pageof 1